Receptor-mediated delivery of an antisense gene to human brain cancer cells.
about
Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.Nanoscale drug delivery systems and the blood-brain barrierCNS penetration of intrathecal-lumbar idursulfase in the monkey, dog and mouse: implications for neurological outcomes of lysosomal storage disorderHighly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells.Drug transport to brain with targeted liposomesRNA interference and nonviral targeted gene therapy of experimental brain cancerNanogels for oligonucleotide delivery to the brain.Drug transport to brain with targeted nanoparticles.OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma.The potential of antisense as a CNS therapeutic.Synergistic enhancement of cancer therapy using a combination of docetaxel and photothermal ablation induced by single-walled carbon nanotubesThe Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain BarrierNew technologies for drug delivery across the blood brain barrier.Intravenous, non-viral RNAi gene therapy of brain cancer.Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy.Receptor binding characteristics and cytotoxicity of insulin-methotrexate.Emerging vectors and targeting methods for nonviral gene therapy.shRNA and siRNA delivery to the brainNanotechnology-novel therapeutics for CNS disordersReceptor-Mediated Drug Delivery Systems Targeting to GliomaTargeting liposomes toward novel pediatric anticancer therapeutics.Antisense-mediated RNA targeting: versatile and expedient genetic manipulation in the brain.Advances in targeted therapeutic agents.Liposomes for brain delivery.Which drug or drug delivery system can change clinical practice for brain tumor therapy?Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.Nonviral gene delivery to human ovarian cancer cells using arginine-grafted PAMAM dendrimer.MicroRNA in Glioblastoma: An Overview.Localization and mobility of glucose-coated gold nanoparticles within the brain.Telomerase - strategies to exploit an important chemotherapeutic target.
P2860
Q26778701-88686C2D-D749-4EEB-8750-CED7A1A48A52Q27026978-C8275D9A-3DA1-4C15-94C0-E054EEF23C1DQ28732722-EB11B1EF-67A4-4DF1-88ED-A3D2E99DE82BQ31137601-8550D743-C0DF-4370-BA9A-CBB8EA9B30E6Q33569479-50BC48FF-C89B-409A-878C-9B2407CE46ECQ33569727-5148DF90-5D8E-4189-B39C-4635396B6884Q33725062-18B39F58-62A6-45B5-986C-B4D1635C9982Q33985140-E5266058-03AC-4E8C-B5F8-30672E8A9DB8Q34062691-C05F7C2C-F70D-477D-97CF-C1F4E35706AFQ35143897-298669E7-DEA3-4E36-A759-43509DCAFCAAQ35556918-7A32FB55-1E95-4F9E-B362-F9151D76CFD8Q35585191-5918BC72-EFC5-4E5A-B58F-30F8A0168666Q35768308-D47BFB7A-1B79-4259-B8CA-7A5992F4B553Q35842672-248AC351-8960-4315-9095-DF57AE5C1499Q36045429-3509B62E-C08D-4CCD-ACFC-9F68046E2969Q36076603-76E57EA9-6586-4021-9EDC-0812C67BECD4Q36580613-1539EB15-0563-47ED-B948-7A709FDB92A9Q36791813-FE969BAB-F02A-4A69-86F6-5BAFB68BD918Q37173643-134E1313-CF24-48F0-B922-A76B43B4F145Q37636271-B0743FEA-B59A-463E-8F68-9151BB45641DQ37684734-CE34DB27-06B1-4326-BFA3-02ECDC5DC8B5Q37910743-23E0BE82-8A64-4176-8F8B-A4BD9A70B3B8Q38029122-017B5EEA-7AFF-430F-A19A-8716581170B2Q38078421-1543CABE-F5C9-4F2F-99A4-29703BF67910Q38090394-035E7BFF-F34D-4168-9830-214581EBF06BQ38401892-197B0CAD-87E7-426D-B78F-338C388754B9Q39664427-6CC13902-00B5-4730-8A32-B332D5F98270Q45864200-31C55156-6C84-40E6-99EE-AB389EBF6ECDQ47142132-726E37A4-A752-4201-88AE-F0319941B03FQ48881407-3C48D6E1-D324-4700-8E5C-E82F8EBE5280Q52549011-5B4C5684-0D54-4910-97DB-9BA01E5E746E
P2860
Receptor-mediated delivery of an antisense gene to human brain cancer cells.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Receptor-mediated delivery of an antisense gene to human brain cancer cells.
@en
Receptor-mediated delivery of an antisense gene to human brain cancer cells.
@nl
type
label
Receptor-mediated delivery of an antisense gene to human brain cancer cells.
@en
Receptor-mediated delivery of an antisense gene to human brain cancer cells.
@nl
prefLabel
Receptor-mediated delivery of an antisense gene to human brain cancer cells.
@en
Receptor-mediated delivery of an antisense gene to human brain cancer cells.
@nl
P2860
P356
P1476
Receptor-mediated delivery of an antisense gene to human brain cancer cells.
@en
P2093
Hwa Jeong Lee
P2860
P304
P356
10.1002/JGM.255
P577
2002-03-01T00:00:00Z